DANIELLE VON MUENSTER: Open Payments
NPI 1548903842 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 30 payments from 11 companies in 2025. Trend: 2023 $250 · 2024 $649 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $396 |
| ABBVIE INC. | 10 | $142 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $125 |
| GENZYME CORPORATION | 4 | $93 |
| Organon LLC | 4 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Janssen Biotech, Inc. | 1 | $26 |
| UCB, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: OPZELURA, Winlevi, DUPIXENT, SKYRIZI, RINVOQ, SPEVIGO, TREMFYA, Bimzelx.
Industry payments across IA — which companies pay providers there.
